Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding Titan Pharmaceuticals Inc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 15 | 17 | +2 |
| Shares | 2.89K | 14.7K | +11.8K (+409.1%) |
| Value | $9.41K | $51.9K | +$42.5K (+451.5%) |
New holders (3)
Institutions that held Titan Pharmaceuticals Inc at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 11,961 | $42.2K | 0.00% |
| CoreCap Advisors, LLC | 88 | $311 | 0.00% |
| BlackRock, Inc. | 6 | $21 | 0.00% |
Sold out (1)
Institutions that held Titan Pharmaceuticals Inc at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| MCF Advisors LLC | 165 | $538 |